VRTX

Q: What is the price of Vertex Pharmaceuticals (VRTX) today?

The price of Vertex Pharmaceuticals (VRTX) today is $ 487.43, with return of 1.2% compared to the last year. The price of Vertex Pharmaceuticals (VRTX) started the year trading around $ 453.36 and today it is at $ 487.43. Follow the real-time price chart, the historical price of Vertex Pharmaceuticals (VRTX) and international markets.

Q: When does Vertex Pharmaceuticals (VRTX) pay dividends?

Vertex Pharmaceuticals (VRTX) did not distribute dividends in the last year.

Q: Is Vertex Pharmaceuticals (VRTX) worth it?

Currently, Vertex Pharmaceuticals (VRTX) is priced at $ 487.43, with a P/E of 30.64%, representing a deviation of -2,735% from its historical average P/E. In the last year, the stock showed a variation of 1.2 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 1.20%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Vertex Pharmaceuticals (VRTX) stock?

Investing in stocks of Vertex Pharmaceuticals (VRTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Vertex Pharmaceuticals (VRTX) yield today?

The yield of Vertex Pharmaceuticals (VRTX) was 4.06% in the last month, 1.20% in the last year and 129.32% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Vertex Pharmaceuticals (VRTX) today, the total investment would be $ 48,743.00, based on the current price of $ 487.43.If past performance were to repeat, the return on your investment would be:In 1 year: $ 49,327.92In 5 years: $ 111,777.45In 10 years: $ 277,913.09It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Vertex Pharmaceuticals Incorporated

Price

$ 487.43

return (12m)

1.20%

p/e

30.64

p/b

6.49

DIVIDEND YIELD

0.00%

price VRTX

VRTX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of VRTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

4.06%

3 months

12.79%

1 year

1.20%

2 years

13.33%

5 years

129.32%

10 years

470.16%

Fundamentals VRTX

review the fundamentals of Vertex Pharmaceuticals shares

P/E

30.64

Sector: -3.67 Industry: -3.67

P/S (Price-to-Sales)

10.09

Sector: -3.88 Industry: -3.88

P/B

6.49

Sector: 1.96 Industry: 1.96

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

15.42%

Sector: -64.91% Industry: -64.91%

ROE

21.18%

Sector: -66.87% Industry: -66.87%

ROIC

29.81%

Sector: -1,295.86% Industry: -1,295.86%

NET MARGIN

32.94%

Sector: -41.02% Industry: -41.02%

GROSS MARGIN

86.24%

Sector: 38.71% Industry: 38.71%

OPERATING MARGIN

39.06%

Sector: -40.91% Industry: -40.91%

EV/EBITDA

25.45

Sector: -3.69 Industry: -3.69

EV/EBIT

26.01

Sector: -3.83 Industry: -3.83

PRICE-TO-ASSETS

4.72

Sector: 1.43 Industry: 1.43

BVPS

73.49

Sector: 1.76 Industry: 1.76

EPS

15.56

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.73

Sector: 0.40 Industry: 0.40

LIABILITIES / ASSETS

0.27

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

9.64%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

11.04%

Sector: - Industry: -

FAIR VALUE OF Vertex Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 487.43

Fair Value

$ 0.00

Upside Return potential.

-67.09%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals VRTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
JNJ	21.68	7.33	33.81%	2.13%	$ 581.04 B	28.46%
PFE	19.50	1.63	8.35%	6.45%	$ 151.53 B	12.42%
ABBV	94.00	0.00	0.00%	2.96%	$ 397.24 B	6.91%
NVO	13.44	6.92	51.50%	3.56%	$ 210.59 B	33.05%
MRK	16.62	0.00	0.00%	2.68%	$ 303.45 B	28.08%
AZN	30.72	6.45	20.99%	0.77%	$ 314.12 B	17.41%
GILD	22.10	8.31	37.62%	2.09%	$ 188.04 B	28.90%
BMY	17.51	-3.63	-20.72%	4.10%	$ 123.50 B	14.64%
ZTS	21.10	16.93	80.25%	1.55%	$ 56.41 B	28.23%
REGN	17.83	2.57	14.41%	0.45%	$ 80.31 B	31.41%
HALO	13.95	16.48	118.17%	0.00%	$ 8.30 B	47.91%
AMGN	26.20	23.33	89.06%	2.54%	$ 201.99 B	20.98%
MCK	26.85	-1,177.17	-4,383.84%	0.32%	$ 116.54 B	1.09%
CAH	31.87	-19.62	-61.56%	0.91%	$ 52.97 B	0.68%
ADMA	18.37	8.92	48.57%	0.00%	$ 3.85 B	42.87%
BIIB	21.83	1.55	7.08%	0.00%	$ 28.23 B	13.07%
HRMY	9.11	2.03	22.24%	0.00%	$ 1.69 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

VRTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated

Average user rating I10

5.0 (18 people)

United States

37 years

Founded: 1989

1991

Time since IPO - 35 years

3.400

Employees

The Company Vertex Pharmaceuticals Incorporated (United States), is listed on Nasdaq with a market value of $ 121.13 Billions, having an equity of $ 18.67 Billions.

With a total of 3.400 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 12.00 Billions, which generated a profit in the amount of $ 3.95 Billions.

As for its main indicators, the Company has a P/E ratio of 30.64, a P/BV ratio of 6.49 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker VRTX.

Market cap

$ 121.13 Billions

Net worth

$ 18.67 Billions

US$ 18,665,800,000.00

Assets

$ 25.64 Billions

US$ 25,643,000,000.00

Total Shares Outstanding

254.00 Millions

254,000,000

Average Daily Trading Volume

$ 1.46 Million

US$ 1,458,972.12

Sector

Health Care

Industry

Biotechnology

VRTX

businesses that generate revenue for Vertex Pharmaceuticals

Regions where Vertex Pharmaceuticals generates revenue

VRTX revenue and profits

Financial Results VRTX

DRAG THE FRAME TO SEE MORE DATA

VRTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/B

0.00

MCK - McKesson

$ 957.36 53,45% (12M)

P/E

26.85

0.32%

ROE

-4,383.84%

P/B

-1,177.17

CAH - Cardinal Health

$ 225.97 79,43% (12M)

P/E

31.87

0.91%

ROE

-61.56%

P/B

-19.62

JNJ - Johnson & Johnson

$ 246.28 53,64% (12M)

P/E

21.68

2.13%

ROE

33.81%

P/B

7.33

PFE - Pfizer

$ 27.14 10,66% (12M)

P/E

19.50

6.45%

ROE

8.35%

P/B

1.63

ABBV - AbbVie

$ 228.44 15,61% (12M)

P/E

94.00

2.96%

ROE

0.00%

P/B

0.00

MRK - Merck & Co.

$ 123.93 41,63% (12M)

P/E

16.62

2.68%

ROE

0.00%

P/B

0.00

AZN - AstraZeneca

$ 206.61 182,81% (12M)

P/E

30.72

0.77%

ROE

20.99%

P/B

6.45

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 957.36 53,45% (12 M)

P/L

26.85

0.32%

ROE

-4,383.84%

P/VP

-1,177.17

CAH - Cardinal Health

$ 225.97 79,43% (12 M)

P/L

31.87

0.91%

ROE

-61.56%

P/VP

-19.62

JNJ - Johnson & Johnson

$ 246.28 53,64% (12 M)

P/L

21.68

2.13%

ROE

33.81%

P/VP

7.33

PFE - Pfizer

$ 27.14 10,66% (12 M)

P/L

19.50

6.45%

ROE

8.35%

P/VP

1.63

ABBV - AbbVie

$ 228.44 15,61% (12 M)

P/L

94.00

2.96%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 123.93 41,63% (12 M)

P/L

16.62

2.68%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 206.61 182,81% (12 M)

P/L

30.72

0.77%

ROE

20.99%

P/VP

6.45

Frequently Asked Questions

What is the price of Vertex Pharmaceuticals (VRTX) today?

The price of Vertex Pharmaceuticals (VRTX) today is $ 487.43, with return of 1.2% compared to the last year. The price of Vertex Pharmaceuticals (VRTX) started the year trading around $ 453.36 and today it is at $ 487.43. Follow the real-time price chart, the historical price of Vertex Pharmaceuticals (VRTX) and international markets.

When does Vertex Pharmaceuticals (VRTX) pay dividends?

Vertex Pharmaceuticals (VRTX) did not distribute dividends in the last year.

Is Vertex Pharmaceuticals (VRTX) worth it?

Currently, Vertex Pharmaceuticals (VRTX) is priced at $ 487.43, with a P/E of 30.64%, representing a deviation of -2,735% from its historical average P/E. In the last year, the stock showed a variation of 1.2 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 1.20%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Vertex Pharmaceuticals (VRTX) stock?

Investing in stocks of Vertex Pharmaceuticals (VRTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Vertex Pharmaceuticals (VRTX) yield today?

The yield of Vertex Pharmaceuticals (VRTX) was 4.06% in the last month, 1.20% in the last year and 129.32% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Vertex Pharmaceuticals (VRTX) today, the total investment would be $ 48,743.00, based on the current price of $ 487.43.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 49,327.92
In 5 years: $ 111,777.45
In 10 years: $ 277,913.09

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

VRTX

Vertex Pharmaceuticals Incorporated

Price

return (12m)

p/e

p/b

DIVIDEND YIELD

Return of VRTX

review the fundamentals of Vertex Pharmaceuticals shares

P/E

P/S (Price-to-Sales)

P/B

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated

United States

37 years

1991

3.400

PROFIT X PRICE VRTX

Financial Results VRTX

VRTX cash flow

asset growth - VRTX

VRTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions